Behavioural and histological effects of preconditioning with lipopolysaccharide in epileptic rats

Neurochemical Research

Volumn 35, Issue 2, 2010, Pages 262-272

  Dmowska, Mirosława ^a   Cybulska, Regina ^b   Schoenborn, Ryszard ^a   Piersiak, Tomasz ^a   Jaworska Adamu, Jadwiga ^b   Gawron, Antoni ^a  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^b UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

Author keywords

Behaviour; Epilepsy; Lipopolysaccharide; Neuroprotection; Preconditioning; Rat

Indexed keywords

LIPOPOLYSACCHARIDE; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BEHAVIOR; BRAIN DEGENERATION; BRAIN INFARCTION PREVENTION; BRAIN NERVE CELL; BRAIN PROTECTION; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; EPILEPSY; EPILEPTIC STATE; FOCAL EPILEPSY; GRAND MAL SEIZURE; ISCHEMIC PRECONDITIONING; LOW DRUG DOSE; MALE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD; TEMPORAL LOBE EPILEPSY;

ANIMALS; BEHAVIOR, ANIMAL; EPILEPSY, TEMPORAL LOBE; HIPPOCAMPUS; ISCHEMIC PRECONDITIONING; LIPOPOLYSACCHARIDES; MALE; PILOCARPINE; RATS; RATS, WISTAR; SEIZURES;

RATTUS;

EID: 76849083197     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-0050-5     Document Type: Article

References (49)

1. CE Murry RB Jennings KA Reimer 1986 Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1124 1136 3769170
2. FR Sharp R Ran A Lu, et al. 2004 Hypoxic preconditioning protects against ischemic brain injury NeuroRx 1 26 35 10.1602/neurorx.1.1.26 15717005 (Pubitemid 46613775)
3. U Dirnagl K Becker A Meisel 2009 Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use Lancet Neurol 8 398 412 10.1016/S1474-4422(09)70054-7 19296922
4. M Perez-Pinzon 2007 Mechanisms of neuroprotection during ischemic preconditioning: lesson from anoxic tolerance Comp Biochem Physiol A Mol Integr Physiol 147 291 299 10.1016/j.cbpa.2006.08.032 17045830 (Pubitemid 46617985)
5. D Zemke JL Smith MJ Reeves, et al. 2004 Ischemia and ischemic tolerance in the brain: an overview NeuroToxicology 25 895 904 10.1016/j.neuro.2004.03.009 15474608 (Pubitemid 39335582)
6. B Schaller R Graf 2002 Cerebral ischemic preconditioning. An experimental phenomenon or a clinical important entity of stroke prevention? J Neurol 249 1503 1511 10.1007/s00415-002-0933-8 12420088 (Pubitemid 35477889)
7. U Dirnagl A Meisel 2008 Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning? Neuropharmacology 55 334 344 10.1016/j.neuropharm.2008.02.017 18402985
8. U Dirnagl RP Simon JM Hallenbeck 2003 Ischemic tolerance and endogenous neuroprotection Trends Neurosci 26 248 254 10.1016/S0166-2236(03)00071-7 12744841 (Pubitemid 36556155)
9. BJ Marsh RL Williams-Karnesky MP Stenzel-Poore 2009 Toll-like receptor signaling in endogenous neuroprotection and stroke Neuroscience 158 1007 1020 10.1016/j.neuroscience.2008.07.067 18809468
10. BJ Marsh MP Stenzel-Poore 2008 Toll-like receptors: novel pharmacological targets for the treatment of neurological diseases Curr Opin Pharmacol 8 8 13 10.1016/j.coph.2007.09.009 17974478 (Pubitemid 351181026)
11. W Song BL Furman JR Parrat 1996 Delayed protection against ischemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin Br J Pharmacol 118 2157 2163 8864556
12. RT Rowland X Meng JC Cleveland, et al. 1997 LPS-induced delayed myocardial adaptation enhances acute preconditioning to optimize postischemic cardiac function Am J Physiol 272 H2708 H2715 9227550
13. YP Wang C Sato K Mizoguchi, et al. 2002 Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase Cardiovasc Res 56 33 42 10.1016/S0008-6363(02)00506-0 12237164 (Pubitemid 35247800)
14. U Heemann A Szabo P Hamar, et al. 2000 Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury: possible connection to an interleukin-6-dependent pathway Am J Pathol 156 287 293 10623677
15. LM Colletti DG Remick Campbell DAJr 1994 LPS pretreatment protects from hepatic ischemia/reperfusion J Surg Res 57 337 343 10.1006/jsre.1994.1152 8072280 (Pubitemid 24283585)
16. K Tasaki CA Ruetzler T Ohtsuki, et al. 1997 Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats Brain Res 748 267 270 10.1016/S0006-8993(96)01383-2 9067475 (Pubitemid 27094913)
17. HL Rosenzweig M Minami NS Lessov, et al. 2007 Endotoxin preconditioning protects against the cytotoxic effects of TNFα after stroke: a novel role for TNFα in LPS-ischemic tolerance J Cereb Blood Flow Metab 27 1663 1674 10.1038/sj.jcbfm.9600464 17327883 (Pubitemid 47476093)
18. SH Ahmed YY He A Nassief, et al. 2000 Effects of lipopolysaccharide priming on acute ischemic brain injury Stroke 31 193 199 10625737
19. R Bordet D Deplanque P Maboudou, et al. 2000 Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance J Cereb Blood Flow Metab 20 1190 1196 10.1097/00004647-200008000-00004 10950379
20. K Furuya L Zhu N Kawahara, et al. 2005 Differences in infarct evolution between lipopolysaccharide-induced tolerant and nontolerant conditions to focal cerebral ischemia J Neurosurg 103 715 723 10.3171/jns.2005.103.4.0715 16266055
21. A Kunz L Park T Abe, et al. 2007 Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen species J Neurosci 27 7083 7093 10.1523/JNEUROSCI.1645-07.2007 17611261 (Pubitemid 47037566)
22. C Mallard H Hagberg 2007 Inflammation-induced preconditioning in the immature brain Semin Fetal Neonatal Med 12 280 286 10.1016/j.siny.2007.01.014 17327146 (Pubitemid 46875055)
23. C Zimmermann I Ginis K Furuya, et al. 2001 Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma Brain Res 895 59 65 10.1016/S0006-8993(01)02028-5 11259760 (Pubitemid 32231138)
24. MP Stenzel-Poore SL Stevens JS King, et al. 2007 Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis Stroke 38 680 685 10.1161/01.STR.0000251444.56487.4c 17261715 (Pubitemid 46184241)
25. RJ Racine 1972 Modification of seizure activity by electrical stimulation: II motor seizure Electroencephalogr Clin Neurophysiol 32 281 294 10.1016/0013-4694(72)90177-0 4110397
26. P Zapater J Javaloy J Román, et al. 1998 Anticonvulsant effects of nimodipine and two novel dihydropyridines (PCA 50922 and PCA 50941) against seizures elicited by pentylenetetrazole and electroconvulsive shock in mice Brain Res 796 311 314 10.1016/S0006-8993(98)00352-7 9689485 (Pubitemid 28343264)
27. König FR, Klippel RA (1970) The rat brain. A stereotaxic atlas of the forebrain and lower parts of the brain stem. R. E. Krieger, Huntington, NY
28. L Turski C Ikonomidou WA Turski, et al. 1989 Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel model of intractable epilepsy Synapse 3 154 171 10.1002/syn.890030207 2648633 (Pubitemid 19073451)
29. MK Hansen KT Nguyen LE Goehler, et al. 2000 Effect of vagotomy on lipopolysaccharide-induced brain interleukin-1 beta protein in rats Auton Neurosci 85 119 126 10.1016/S1566-0702(00)00230-7 11189018 (Pubitemid 30947035)
30. NP Turrin D Gayle SE Ilyin, et al. 2001 Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide Brain Res Bull 54 443 453 10.1016/S0361-9230(01)00445-2 11306198 (Pubitemid 32288728)
31. A Beishuizen LG Thijs 2003 Endotoxin and the hypothalamo-pituitary- adrenal (HPA) axis J Endotoxin Res 9 3 24 12691614
32. Z Guan J Fang 2006 Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats Brain Behav Immun 20 64 71 10.1016/j.bbi.2005.04.005 15922558 (Pubitemid 41814665)
33. H Wu WJ Friedman CF Dreyfus 2004 Differential regulation of neurotrophin expression in basal forebrain astrocytes by neuronal signals J Neurosci Res 76 76 85 10.1002/jnr.20060 15048931 (Pubitemid 38445565)
34. WA Banks SA Farr ME La Scola, et al. 2001 Intravenous human interleukin-1 alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum J Pharmacol Exp Ther 299 536 541 11602664
35. P Rada GP Mark MP Vitek, et al. 1991 Interleukin-1 beta decreases acetylcholine measured by microdialysis in the hippocampus of freely moving rats Brain Res 550 287 290 10.1016/0006-8993(91)91330-4 1884236
36. Y Li L Liu J Kang, et al. 2000 Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression J Neurosci 20 149 155 10627591
37. M Ingvar 1986 Cerebral blood flow and metabolic rate during seizures. Relationship to epileptic brain damage Ann N Y Acad Sci 462 194 206 10.1111/j.1749-6632.1986.tb51254.x 3518570
38. CG Wasterlain DG Fujikawa L Penix, et al. 1993 Pathophysiological mechanisms of brain damage from status epilepticus Epilepsia 34 Suppl 1 S37 S53 10.1111/j.1528-1157.1993.tb05905.x 8385002
39. TN Lin YY He G Wu, et al. 1993 Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats Stroke 24 117 121 8418534
40. T Masada Y Hua G Xi, et al. 2001 Attenuation of ischemic brain edema and cerebrovascular injury after ischemic preconditioning in the rat J Cereb Blood Flow Metab 21 22 33 10.1097/00004647-200101000-00004 11149665
41. Q Pu R Bordet E Robin, et al. 1999 Low dose of lipopolysaccharide induces a delayed enhanced nitric oxide-mediated relaxation in rat aorta Eur J Pharmacol 377 209 214 10.1016/S0014-2999(99)00420-3 10456432 (Pubitemid 29336044)
42. D Deplanque R Bordet 2000 Pharmacological preconditioning with lipopolysaccharide in the brain Stroke 31 1463 1466
43. F Puisieux D Deplanque Q Pu, et al. 2000 Differential role of nitric oxide pathway and heat shock protein in preconditioning and lipopolysaccharide- induced brain ischemic tolerance Eur J Pharmacol 389 71 78 10.1016/S0014- 2999(99)00893-6 10686298 (Pubitemid 30109369)
44. DA Dawson K Furuya J Gotoh, et al. 1999 Cerebrovascular hemodynamics and ischemic tolerance: lipopolysaccharide-induced resistance to focal cerebral ischemia is not due to changes in severity of the initial ischemic insult, but is associated with preservation of microvascular perfusion J Cereb Blood Flow Metab 19 616 623 10.1097/00004647-199906000-00004 10366191
45. M Bastide P Gele O Petrault, et al. 2003 Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic tolerance J Cereb Blood Flow Metab 23 399 405 10.1097/00004647-200304000-00003 12679716
46. N Arican M Kaya R Kalayci, et al. 2006 Effects of lipopolysaccharide on blood-brain barrier permeability during pentylenetetrazole-induced epileptic seizuresin rats Life Sci 79 1 7 10.1016/j.lfs.2005.12.035 16434059 (Pubitemid 44255532)
47. HJ Steiger D Hänggi 2007 Ischaemic preconditioning of the brain, mechanisms and applications Acta Neurochir (Wien) 149 1 10 10.1007/s00701-006- 1057-1 (Pubitemid 46090183)
48. HL Rosenzweig NS Lessov DC Henshall, et al. 2004 Endotoxin preconditioning prevents the cellular inflammatory response during ischemic neuroprotection in mice Stroke 35 2576 2581 10.1161/01.STR.0000143450.04438.ae 15375302 (Pubitemid 39458420)
49. KP Doyle RP Simon MP Stenzel-Poore 2008 Mechanisms of ischemic brain damage Neuropharmacology 55 310 318 10.1016/j.neuropharm.2008.01.005 18308346